Article Text

Download PDFPDF

Rapid reviews methods series: considerations and recommendations for evidence synthesis in rapid reviews
  1. Valerie J King1,2,
  2. Barbara Nussbaumer-Streit3,
  3. Elizabeth Shaw1,
  4. Declan Devane4,5,
  5. Leila Kahwati6,
  6. Meera Viswanathan6,
  7. Gerald Gartlehner3,7
  8. on behalf of the Cochrane Rapid Reviews Methods Group
  1. 1 Center for Evidence-based Policy, Oregon Health & Science University School of Medicine, Portland, Oregon, USA
  2. 2 Health Management & Policy, Health Systems & Policy, OHSU-PSU School of Public Health, Portland, Oregon, USA
  3. 3 Evidence-based Medicine and Evaluation - Cochrane Austria, Danube University Krems, Krems, Austria
  4. 4 School of Nursing and Midwifery, University of Galway, Galway, Ireland
  5. 5 HRB - Trials Methodology Research Unit, Galway, Ireland
  6. 6 RTI International, Research Triangle Park, North Carolina, USA
  7. 7 Danube University Krems, Krems, Austria
  8. 8 University for Continuing Education Krems, Krems, Austria
  1. Correspondence to Dr Valerie J King; kingv{at}ohsu.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Introduction

This paper provides additional education and considerations from the Cochrane Rapid Review Methods Group (RRMG) around the synthesis of findings in a rapid review (RR), including summarising included studies, providing a narrative interpretation of findings, determining the appropriateness of conducting a meta-analysis and using systematic reviews (SRs) as studies included in an RR.1

RRs are an increasingly common knowledge synthesis product used to support evidence synthesis needs in situations where time and other resources may limit the use of full SRs.1 Studies of RR methods and reporting have found that most RRs provide a descriptive synthesis of results, that a minority provide a meta-analysis and that few are transparent about why particular synthesis methods were selected.2–5 This paper summarises advice for synthesising evidence for RRs from the updated Cochrane Rapid Reviews Methods Guidance to help researchers effectively conduct RRs, including when to consider quantitative synthesis and how to integrate SRs and primary studies in the synthesis process.1 The RRMG’s four recommendations for RR evidence synthesis are summarised in table 1.

Table 1

Recommendations for rapid review evidence synthesis

Table 2

Example of a combined study characteristics and key outcome evidence table

Table 3

Examples of evidence synthesis and interpretation statements

Evidence synthesis for RRs

An end-user orientation guides the development of an appropriate synthesis plan, which should be included in the protocol and informed by the involvement of knowledge users.1 6 The analysis plan should prioritise and select key PICO (Population, Intervention, Comparator, Outcomes) elements, with particular attention to the outcomes most critical for decision-making.1 7 The basic principles of evidence synthesis are the same between SRs and RRs, and this paper highlights opportunities to accelerate and streamline processes when conducting an RR, along with which key practices for SRs should be followed.

Provide a descriptive summary of the included studies

A descriptive summary of the included studies helps to ground the reader in what studies were included and confirm that the studies have similar PICOs to assist in determining whether it is possible to pool their results. We recommend structuring the descriptive summary of included studies around the PICO elements. Additional descriptions such as the dates of studies, locations or health systems in which the studies were conducted, study design(s) and ways in which outcomes were measured and reported should be included as appropriate to the RR question(s). Providing a summary in an evidence table or an alternative format such as a descriptive graphical display can help streamline RR production and presentation.

Evidence tables lay out the important characteristics of a study in a brief tabular form. Some evidence tables include results, or they may be presented in a separate table. Table 2 provides an example of the format of an evidence table that incorporates results, adapted from a recent RR of bariatric surgery.8 An RR by Uhl et al on the use of telehealth for substance use disorder treatment includes a table with details of the treated population, the telehealth intervention, the comparator and the number of studies and participants for each combination of these elements.9 Pisavadia et al conducted an RR of health economic evaluations of care for perinatal anxiety disorders that uses a table to map out how costs of maternal illness, interventions and comparators were evaluated across studies.10 As these three examples illustrate, there is not one correct form for evidence tables, with each constructed to meet the RR’s needs. Appendix K of the National Institute for Health and Care Excellence’s methods document for development of public health guidance provides evidence table templates for various types of studies and reviews.11 The Cochrane Handbook provides guidance related to summarising study characteristics, including using evidence tables to prepare for evidence synthesis.12

Perform a synthesis of the findings

An RR provides a narrative interpretation of the compiled evidence, with or without meta-analysis, to help users fully understand the collected evidence.1 Even when a meta-analysis is feasible and planned, the accompanying narrative synthesis can aid readers in comprehending the outcomes by interpreting and contextualising them rather than solely presenting numerical data. Campbell and colleagues study of SRs of public health interventions employing narrative synthesis of quantitative data found that most fall short in terms of describing the method and theory used, investigation of heterogeneity, and discussion of limitations.13 Their study gives an overview of best practices for narrative synthesis, particularly for complex interventions, based largely on the Economic and Social Research Council guidance by Popay and colleagues.14

Table 3 contains several examples of evidence synthesis statements for several outcomes from the RR of bariatric surgery by Durbin and colleagues, including statements based on meta-analyses as well as narrative summaries of study findings.8 A summary of findings (SOF) table, as described by GRADE (Grading of Recommendations, Assessment, Development and Evaluation), is also an approach to organise the quantitative findings of studies for each selected outcome, along with the finding’s certainty of evidence. The RR of telehealth interventions for substance use disorders by Uhl et al includes such an SOF table.9

The Cochrane Handbook includes a chapter regarding the development of SOF tables.15 While the Cochrane guidance was written with SRs in mind, the principles and formats can easily be adapted for RRs and another Cochrane RRMG article in this series specifically addresses their application of GRADE and certainty of evidence rating for RRs.7

If a meta-analysis is not possible RR authors may also consider using the Synthesis Without Meta-analysis (SWiM) reporting guideline as a guide to help promote transparency and completeness in the narrative presentation of evidence synthesis.16 The SWiM guidelines suggest that authors describe the synthesis of findings for each comparison and outcome, that the synthesis addresses each key question and specifies which included studies contributed to the findings.16

Consider a meta-analysis if appropriate and resources permit

If sufficient data, both in quantity and quality, are available, then a meta-analysis is often the most useful and efficient way of providing data synthesis in an RR. Meta-analysis may be inappropriate not only when there are insufficient studies for a given comparison, but also in situations where, despite having several eligible studies, factors such as heterogeneity in study design, PICO elements or concerns about the quality and consistency of the data, may render it an inappropriate synthesis method.17 The standards for conducting an SR meta-analyses generally apply to RRs, and authors should consult the Cochrane Handbook for the full details regarding meta-analytic techniques.17 When performed, meta-analysis for an RR can be streamlined by conducting only the pooled analyses on comparisons most critical for the decision-making process. Single reviewer data entry with checking by another reviewer is another common shortcut used in RRs.

Consider how to synthesise evidence when including one or more SRs

Some RRs include only primary studies and others may incorporate additional primary studies with one or more existing SRs. Overviews of SRs without additional primary studies are not included in our RR guidance but are addressed in the Cochrane Handbook chapter on overviews of reviews.18 When one or more SRs are available to help address an RR question, the selection criteria for incorporating SRs may include using the most recent, most methodologically robust, or most comprehensive, of the SRs most closely matching the RR research question. We recommend that if multiple SRs are included, the RR also considers the overlap of any primary studies to avoid statistical errors from double counting in meta-analysis. A formal study of overlap does not need to be undertaken, overlapping studies may be presented in a table that identifies which are included in each SR.

When SRs are included in an RR, synthesis may involve adding new primary studies to an existing meta-analysis. Typically, once a primary SR is identified that matches the research question then primary studies that meet the inclusion criteria and were published after the search date of the included SR are added for meta-analyses presented in the RR.

If an updated meta-analysis incorporating new primary studies is planned, it is usually necessary to abstract data from each study in the SR for entry into the software package along with data from the new primary studies. If the included SR does not use meta-analysis, authors should assess whether meta-analysis is now appropriate, combining primary studies from the SR and the additional studies. When it is not possible or feasible to conduct a new meta-analysis then the narrative synthesis should provide an interpretation of the additional studies in the context of the existing SR, exploring the similarities and differences in their PICO elements, settings, study designs and results.

Conclusions

RRs should always include a descriptive summary of included studies and provide a narrative interpretation of the findings. When feasible, authors should consider conducting meta-analyses since this is often the most time efficient way of presenting synthesised evidence and drawing conclusions from the data. Synthesis methods are similar in SR and RR, but authors of RRs can accelerate the evidence synthesis by addressing more tightly focused questions, emphasising only the most critical PICO elements, using an experienced team, and performing single reviewer data abstraction with checking for tables and meta-analyses. Authors can also limit the amount of descriptive text written when the data are presented elsewhere in the RR, such as in evidence tables. Authors should provide transparency about the shortcuts employed and their potential impact on the bias of the RR given that some shortcuts may be more (ie, omission of a protocol) or less (ie, limitation to English language publications) likely to introduce bias.19 Finally, although decision-makers need and want information quickly, RR authors should clearly express the potential limitations of RRs compared with SRs and how certain we may be in the interpretation and implementation of RR findings in the realms of clinical care, health policy and public health.20

Ethics statements

Patient consent for publication

Ethics approval

Not applicable.

Acknowledgments

We would like to thank our colleagues who worked with the Cochrane RRMG convenors to create a series of articles in the BMJ Evidence-Based Medicine journal explaining and elaborating our recommendations for conducting RRs.

References

Footnotes

  • X @drvalking, @decdevane

  • Collaborators On behalf of the Cochrane Rapid Reviews Methods Group.

  • Contributors All authors contributed to the conceptualisation of this paper (VJK, BN-S, ES, DD, LK, MV, GG). VJK wrote the first draft of the manuscript, and revised the manuscript with input from all coauthors. All authors read and approved the final version. VJK and some coauthors (BN-S, DD and GG) planned the article revision and VJK wrote the revised manuscript. VJK is the guarantor and attests that all authors meet authorship cirteria and that no others have been omitted.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests All authors conduct evidence syntheses and have done methodological research on RRs but do not have other specific competing interests. VJK: no competing interests. BNS: no competing interests. ES: no competing interests. DD: works part time for Cochrane Ireland and Evidence Synthesis Ireland, which are funded within the University of Ireland Galway (Ireland) by the Health Research Board (HRB) and the Health and Social Care, Research and Development (HSC R&D) Division of the Public Health Agency in Northern Ireland. LK: no competing interests. MV: no competing interests. GG: no competing interests.

  • Provenance and peer review Commissioned; externally peer reviewed.